Skip to main content
Safety Profile of Upadacitinib up to 3 Years of Exposure in Patients with Rheumatoid Arthritis https://t.co/T3cXYlCSRC #RA #Upadacitinib 3 yr safety data
Peter Nash
07-11-2020
×